Author: Tulya

  • All
  • Blog
  • Grants
  • News
  • Newsletter
  • Press Release
  • Publications
  • Uncategorized
  • Webinar
ToxTracker MACSQuant X
Tulya Kavaklioglu

Can ToxTracker replace the in vitro micronucleus test?

[vc_row css=".vc_custom_1716384043706{margin-top: 30px !important;padding-top: 3% !important;padding-right: 3% !important;padding-bottom: 3% !important;padding-left: 3% !important;background-image: url( !important;}"][vc_column width="2/3"][vc_row_inner][vc_column_inner offset="vc_col-lg-offset-0 vc_hidden-xs"][vc_empty_space height="75px"][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner width="1/3"][vc_column_text css=".vc_custom_1716384008958{padding-top: 2% !important;padding-bottom: 3.5% !important;background-color: #006600 !important;border-radius: 35px !important;}"] Case Study [/vc_column_text][/vc_column_inner][vc_column_inner width="1/3"][vc_column_text css=".vc_custom_1716384016286{padding-top: 2% !important;padding-bottom: 3.5% !important;background-color: #006600 !important;border-radius: 35px !important;}"] ToxTracker [/vc_column_text][/vc_column_inner][vc_column_inner width="1/3"][/vc_column_inner][/vc_row_inner][vc_column_text] Can ToxTracker replace the in vitro...

Tulya Kavaklioglu

Webinar: Integrating ReproTracker into DART AOP for mechanism-based teratogenicity assessment

[vc_row][vc_column][vc_column_text]Webinar on ReproTracker & DART AOP framework When: 20 June 2024, 3.00-5.00 pm CET[/vc_column_text][mkd_button size="" type="" hover_type="" target="_blank" icon_pack="" font_weight="" text="Register Here" link="" margin="20px 20px 0px 0px"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Testing for developmental toxicity according to the current guidelines requires large numbers of animals. In addition to the ethical considerations...

Better in vitro dosing partners
Tulya Kavaklioglu

Create2Solve Funded Consortium Annual Progress Meeting

Toxys is one of the five partners in the ‘Better in vitro dosing’ consortium, funded by ZonMw’s Create2Solve subsidy program. The aim of the project is to develop alternative dosing technologies for in vitro assays to better reflect human exposure. These novel dosing approaches should...

Tulya Kavaklioglu

Toxys publication on OECD ring trial validation of ToxTracker

[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE Toxys reports positive results from the OECD ring trial validation of ToxTracker in a peer-reviewed article Oegstgeest, The Netherlands. April 9th, 2024 - Today Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©. ToxTracker is an in...

Tulya Kavaklioglu

Toxys Awarded Phase 1 Project in CRACK IT Challenge

CRACK IT is a challenge-led competition that funds collaborations between industry, academics and SMEs to solve business and scientific Challenges which will deliver 3Rs benefits, either by improving business processes or developing a commercial product. Depending on the Challenge, contracts of up to £1M for...

ToxTracker Kit
Tulya Kavaklioglu

OECD Peer-Review of the Interlaboratory Validation of ToxTracker

[vc_row][vc_column][vc_column_text]In Q3 2023, the OECD has conducted the peer-review of the interlaboratory validation of the ToxTracker assay by a panel of experts, nominated by their National Coordinators. A report on the successful ToxTracker validation results was recently published on the OECD website. Significance of the validation The...